Experiment 66845

Compounds isolated

Details

PropertyValue
Pharmacology
Administration routeORAL
OrganismEmpty organism
CitationSHAHEEN,NJ: ROBERTSON,DJ: CROSBY,MA: FURS,SJ: MAY,DT: HARLAN,WR: GRIMM,IS: ISAACS,KL: BOZYMSKI,EM:. (1999). HYOSCYAMINE AS A PHARMACOLOGICAL ADJUNCT IN COLONOSCOPY: A RANDOMIZED, DOUBLE BLINDED, PLACEBO-CONTROLLED TRIAL.. 94(10)
Amount utilized
Compound isolated
DiseaseA TOTAL OF 165 PATIENTS UNDERGOING ELECTIVE COL9ONOSCOPY WERE RANDOMIZED IN A DOUBLE-BLIND FASHION TO ONE OF THREE ARMS: INTRAVENOUS HYOSCYAMINE (0.25 MG), ORAL HYOSCYAMINE (0.25 MG), OR PLACEBO, ADMINISTERED 20-40 MIN BEFORE COLONSCOPY. PRIMARY OUTCOME MEASURES INCLUDED INSERTION TIME TO CECUM, PATIENT'S ASSESSMENT OF PAIN, AND PHYSICIAN ASSESSMENT OF SPASM. SECONDARY OUTCOME MEASURS INCLUDED AMOUNT OF ANALGESIC MEDICATIONS USED, TOTAL PROCEDURE TIME, AMOUNT AND TYPE OF PATHOLOGY VISUALIZED, AND PHYSICIAN ASSESSMENT OF PATIENTS'S PAIN. THIS RANDOMIZED, BOUBLE-BLIND, PALCEBO-CONTROLLED TRIAL DID NOT DEMOSTRATE EFFICACY OF EITHER INTRAVENOUS OR ORAL HYOSCYAMINE AS A PREMEDICATION FRO COLONSCOPY.
Dose amount0.25 MG
Number1
Qualitative resultINACTIVE
AnimalHUMAN ADULT
Per unitPERSON
Dose expressionDOSE
GenderGIVEN TO BOTH SEXES